Response: Re: Adjuvant treatment of high-risk, radically resected rastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [5]

Stefano Cascinu, Mario Scartozzi, Carlo Barone, Roberto Labianca, Armando Santoro, Carlo Carnaghi, Giordano D. Beretta, Vincenzo Catalano, Sandro Barni, Luciano Frontini

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1346-1347
Number of pages2
JournalJournal of the National Cancer Institute
Issue number17
Publication statusPublished - Sep 5 2007

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this